Press release
Global Albumin Market is set to grow at a CAGR of 6% by 2026 - Rising Preference for Recombinant Albumin in Drug Delivery
An Increasing Demand for Albumin in Research & Development and Clinical Trials is Driving the Growth of the Albumin Market
Albumin-based therapeutic agents are especially used for treating and diagnosing malignant, inflammatory, metabolic, and viral diseases. Considering the commercial success of products which use albumin as a drug carrier and the ongoing clinical trials albumin is attracting the interest of researchers, pharmaceutical companies and biotechnological companies.
Albumin-Based Nanoparticles Provide Promising Drug Delivery System for Cancer Treatment
Albumin is a versatile biomaterial for the synthesis of nanoparticles. The efficiency of the albumin-based delivery resides in its ability to enrich tumor targeting and accumulation. Furthermore, albumin can bind to special receptors overexpressed on cancer cells and enhance nanoparticle binding and internalization.
Adoption of Recombinant Albumin over Serum-based Albumin for Drug Delivery
As regulatory guidelines have driven the demand for animal-free options, there has been a decline in the usage of serum-derived albumin. With the availability of recombinant albumin, historical risks associated with human serum albumin have been eliminated. It also provides a simple solution to traditional formulation strategies and provides a more cost-effective and a single solution to many stability problems.
Potential Role of Human Serum Albumin in Covid-19 Patients Boosts the Growth of the Global Albumin Market
Albumin downregulates the expression of the ACE2 receptors and has been shown to improve the ratio of arterial partial pressure of oxygen/fraction of inspired oxygen in patients with acute respiratory distress syndrome as soon as 24 hours after treatment and with an effect which persists for at least seven days. Moreover, researchers who have studied the clinical characteristics of Covid-19 patients have reported that low serum albumin on presentation in COVID-19 infection is associated with a higher cases of serious results like kidney injury, cardiac injury, and higher mortality.
Upcoming Market Challenges: Albumin Market
Stringent government regulations, limited reimbursement, move towards serum-free solutions, and side effects associated with the consumption of albumin are the primary factors restraining the growth of the albumin market.
North America Holds the Highest Share but Asia-Pacific is Poised to Witness a Significant Growth in Albumin Market
North America holds the highest market share in the global albumin market. This can be mainly attributed to the rising demand for albumin-based R&D activities, the presence of advanced and innovative healthcare infrastructure, an ever increasing demand for albumin in many non-therapeutics applications, and the presence of key market players in this region.
Competitive Landscape Analysis: Albumin Market
The global albumin market is marked by the presence of well-established and emerging market players such as Baxter International Inc., China Biologic Products Inc, Grifols S.A., Apotex Corp., and InVitria, among others.
Growth Strategies Adopted by Leading Companies to Increase their Market Share in the Albumin Market
All the leading players operating in the global albumin market are adopting both organic and inorganic growth strategies such as collaborations, acquisitions, innovations and expansions to garner a larger market share.
Get More Detailed Insights on Albumin Market Report with a Sample PDF @ https://meditechinsights.com/global-albumin-market/
Ruta Halde
Associate, Medi-Tech Insights
121/7E Avenue Franklin Roosevelt,
1050 Brussels, Belgium
+32 498 86 80 79
info@meditechinsights.com
https://meditechinsights.com/
Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Albumin Market is set to grow at a CAGR of 6% by 2026 - Rising Preference for Recombinant Albumin in Drug Delivery here
News-ID: 3055084 • Views: …
More Releases from Medi-Tech Insights
Sterilization Equipment Market Shows Strong Investment Potential with 7-9% CAGR …
The global sterilization equipment market is set to experience significant growth, with an expected CAGR of 7-9% over the next 5 years. This growth is driven by increasing demand for sterilization in healthcare facilities, stringent infection control regulations, rising surgical procedures, necessity to curb hospital-acquired infections (HAIs), and advancements in sterilization technologies.
Sterilization equipment plays a critical role in ensuring the safety and hygiene of medical instruments, devices, and environments. These…
Global Biologics Market Set to Expand at 10-12% CAGR from 2024 to 2029: Medi-Tec …
The global biologics market is set to witness a growth rate of 10-12% in the next 5 years. Rising prevalence of chronic diseases; continued advancements in biotechnology; growing investment in biopharmaceutical R&D; and growing strategic partnerships between biotech firms & larger pharmaceutical companies are some of the key factors driving the biologics market.
Biologics are a class of medications derived from living organisms, including proteins, sugars, and nucleic acids among others.…
Telemedicine Market to Grow at 16-18% CAGR By 2029, Fueled by Tech Advancements …
The global telemedicine market is set to witness a robust growth rate of 16-18% over the next five years. This growth is driven by the increasing adoption of digital healthcare solutions, a rise in chronic disease prevalence, an aging population demanding more accessible care, technological advancements in telehealth platforms, growing government support, and the shift toward remote patient monitoring and virtual care solutions.
Telemedicine refers to the remote diagnosis, treatment, and…
High Flow Oxygen Therapy Market Set to Grow at 7% CAGR by 2029 Driven by Rising …
The high flow oxygen therapy (HFOT) market is growing at a projected compound annual growth rate (CAGR) of around 7% in the forecast period. Key drivers include the rising prevalence of respiratory diseases such as COPD, pneumonia, and acute respiratory failure, along with increased adoption of non-invasive treatments. Technological advancements in HFOT devices and the growing elderly population further support market growth. However, high device costs and limited reimbursement in…
More Releases for Albumin
rHu Albumin Market Key Players Analysis - Merck KGaA, HiMedia Laboratories Pvt. …
"rHu Albumin Market" in terms of revenue was estimated to be worth $94.88 million in 2023 and is poised to reach $218.56 million by 2031, growing at a CAGR of 11.16% from 2024 to 2031 according to a new report by Insight Ace Analytic.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1482
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global rHu Albumins market are:
• Increase in…
Rhu Albumin Market Future Business Opportunities 2024-2031 | Albumin Bioscience, …
The Latest research report on the Rhu Albumin Market 2024 provides a comprehensive analysis of the current market landscape, with forecasts extending to 2031. This study combines qualitative and quantitative insights to highlight significant market developments, challenges, competitive dynamics, and potential opportunities and trends shaping the Rhu Albumin Market. The report covers market size, recent trends, growth projections, market share, and development status. Additionally, it examines government policies, market dynamics,…
Rhu Albumin Market Growth in Future Scope 2024-2031 | HiMedia Laboratories Pvt. …
Rhu Albumin Market Trends Overview 2024-2031:
A new Report by Coherent Market Insights, titled "Rhu Albumin Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031," offers a comprehensive analysis of the industry, which comprises insights on the Rhu Albumin market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
This report has a complete table of contents, figures, tables, and charts, as well as insightful…
rHu Albumin Market: A Catalyst for Innovation in Trauma Care, Albumin Replacemen …
"rHu Albumin Market" in terms of revenue was estimated to be worth $94.88 million in 2023 and is poised to reach $218.56 million by 2031, growing at a CAGR of 11.16% from 2024 to 2031 according to a new report by Insight Ace Analytic.
Get Free Sample Report @ https://www.insightaceanalytic.com/request-sample/1482
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global rHu Albumins market are:
• Increase in prevalence of rare diseases,…
Exploring the Growing Demand for Albumin in the Global Albumin Market
Introduction:
Albumin is a protein that is primarily produced by the liver and is found in human blood plasma. It plays a crucial role in maintaining the osmotic pressure of blood and transporting various substances such as hormones, fatty acids, and drugs. Albumin is widely used in various medical applications such as blood volume expansion, treatment of burns, liver diseases, and hypovolemic shock. With the growing prevalence of chronic diseases such…
Albumin Market: Therapeutic Action of Albumin on Liver Function and Blood Circul …
The use of albumin to treat multiple types of deficiencies, including those related to blood volume, is giving an impetus to market growth. It is a high-utility, human-derived protein that has applications across a spectrum of medical operations. Conditions such as hypoalbuminemia, caused by severe injuries, and rapid protein loss due to third-degree burns can be effectively managed through intravenous administration of albumin. Furthermore, albumin administration is the last resort…
